Acute lymphoblastic leukaemia trials in Spain
39 of 41 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia
- Where
- Esplugues de Llobregat
- Age
- 1 year to 64 years
- People
- 130 worldwide
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07223021 · EU 2025-523096-34-00 - Phase 2/3Taking peopleA Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)
- Where
- Badalona, Madrid, Oviedo, Pozuelo de Alarcón, Salamanca, Valencia
- Age
- 12 years and over
- People
- 340 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07570173 · EU 2025-522267-15-00 - Phase 4Taking peopleAsciminib Roll-over Study
- Where
- Badalona, Barcelona, Bilbao, L'Hospitalet de Llobregat, Madrid, Santa Cruz de Tenerife, Santiago de Compostela, Sevilla, Valencia
- Age
- 7 years to 100 years
- People
- 347 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04877522 · EU 2023-507557-16-00 - Phase 2Not yet taking people in SpainInotuzumab as Post-Trasplantation Therapy for Adult High-risk B-cell Precursor Acute Lymphoblastic Leukemia
- Where
- Badalona, Barcelona, Madrid, Málaga, Salamanca, San Sebastián, Santander, Seville, Valencia
- Age
- 18 years and over
- People
- 30
- Run by
- PETHEMA Foundation
See details and how to joinNCT07862946 - Phase 1/2Taking peopleSubstudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Where
- Barcelona, Esplugues De Llobregat, Madrid, Valencia
- Age
- 6 months to 25 years
- People
- 90 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00 - Phase 3Taking peopleInternational Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)
- Where
- Alicante, Barakaldo, Barcelona, Esplugues de Llobregat, Madrid, Málaga, Murcia, Palma, Santiago de Compostela, Sevilla, Valencia, Zaragoza
- Age
- 1 year to 64 years
- People
- 750 worldwide
- Run by
- Charite University, Berlin, Germany
See details and how to joinNCT07476729 · EU 2023-509392-17-00 - Phase 3Taking peopleInterfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
- Where
- Barcelona, Madrid, Sevilla, Valencia
- Age
- 1 day to 1 year
- People
- 160 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05327894 · EU 2022-502503-30-00 - Phase 1/2Taking peopleStudy of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
- Where
- Badalona, Barcelona, Salamanca, Santander
- Age
- 12 years and over
- People
- 83 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07109219 · EU 2025-522372-93-00 - Phase 3Taking peopleSingle-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
- Where
- Badalona, Barcelona, Elche, Madrid, Santander
- Age
- 18 years and over
- People
- 63 worldwide
- Run by
- CSL Behring
See details and how to joinNCT07648264 · EU 2026-525626-38-00 - Phase 1/2Taking peopleAZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
- Where
- Barcelona, Madrid, Salamanca, Sevilla, Valencia
- Age
- 12 years and over
- People
- 255 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06137118 · EU 2023-505840-20-00 - Phase 1/2Taking peopleSafety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
- Where
- Barcelona, Madrid, Valencia
- Age
- 1 year to 17 years
- People
- 70 worldwide
- Run by
- Incyte Biosciences International Sàrl
See details and how to joinNCT03934372 · EU 2023-509699-41-00 - Phase 1/2Taking peopleA Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- Where
- L'Hospitalet de Llobregat, Sevilla, Valencia
- Age
- 30 days and over
- People
- 447 worldwide
- Run by
- Syndax Pharmaceuticals
See details and how to joinNCT04065399 · EU 2024-513759-34-00 - Phase 1Taking peopleA Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
- Where
- Barcelona, Madrid
- Age
- 0 years to 18 years
- People
- 30 worldwide
- Run by
- Autolus Limited
See details and how to joinNCT06173518 · EU 2023-506307-26-00 - No phaseNot yet taking people in SpainDigital Patient-Reported Assessment in Older Adults With Acute Leukemia
- Where
- Oviedo
- Age
- 65 years and over
- People
- 20
- Run by
- Fundación para la Investigación Biosanitaria del Principado de Asturias
See details and how to joinNCT07597590 - Phase 1/2Not yet taking people in SpainStudy of the safety and efficacy of asciminib in pediatric and young adult participants with r/r Ph+ or ABL-class Ph-like ALL
- Where
- Barcelona, Esplugues de Llobregat, Madrid
- Age
- Up to 64 years
- People
- 22 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2025-522019-40-00 - Phase 2Taking peopleA Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL
- Where
- Barcelona, Esplugues de Llobregat, Madrid, Murcia, Santiago De Compostela, Sevilla, Valencia
- Age
- 1 year to 17 years
- People
- 100 worldwide
- Run by
- Pfizer
See details and how to joinNCT05748171 · EU 2023-509810-13-00 - Phase 2Not yet taking people in SpainA phase II clinical trial of inotuzumab ozogamicin as prophylaxis for relapse in patients with lymphoblastic leukaemia after allogeneic stem cell haemotopoietic transplantation
- Where
- Badalona, Barcelona, Donostia, Madrid, Málaga, Salamanca, Santander, Sevilla, Valencia
- Age
- 18 years and over
- People
- 30
- Run by
- Fundacion PETHEMA
See details and how to join2026-525964-17-00 - Phase 2/3Taking peopleAllogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
- Where
- Barcelona, Murcia, Oviedo
- Age
- 1 month to 18 years
- People
- 1,800 worldwide
- Run by
- St. Anna Kinderkrebsforschung
See details and how to joinNCT01949129 · EU 2024-512657-24-00 - Phase 3Taking peopleA Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
- Where
- Barakaldo, Barcelona, Esplugues de Llobregat, Madrid, Palma, Sevilla, Valencia, Zaragoza
- Age
- 0 years to 45 years
- People
- 6,430 worldwide
- Run by
- Mats Heyman
See details and how to joinNCT04307576 · EU 2022-501050-11-01 - Phase 1Taking peopleA Phase I Clinical Trial of CART cell therapy for refractory/ relapsed acute lymphoblastic leukemia with unmet needs in children, adolescents and young adults: feasibility and safety study (REALL_CART)
- Where
- Madrid
- Age
- Up to 64 years
- People
- 10
- Run by
- Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Paz
See details and how to join2023-509723-41-01 - Phase 2Not yet taking people in SpainA PRECISION MEDICINE RANDOMIZED TRIAL FOR PATIENTS WITH RELAPSED OR REFRACTORY T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA BASED ON A FUNCTIONAL APPROACH. ALL-TARGET TRIAL
- Where
- Badalona, Barcelona, Donostia, Madrid, Málaga, Murcia, Salamanca, Santander, Sevilla, Valencia
- People
- 86 worldwide
- Run by
- Centre Hospitalier De Versailles
See details and how to join2024-516570-30-00 - Phase 1/2Taking peopleInotuzumab ozogamicin for Acute Lymphoblastic Leukemia
- Where
- Barcelona, Esplugues De Llobregat, Madrid, Valencia
- Age
- Up to 17 years
- People
- 142 worldwide
- Run by
- Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
See details and how to join2023-504694-20-00 - Phase 1/2Taking peoplePhase I/IIa clinical trial with dose escalation to evaluate safety and efficacy of the infusion of CART84 in relapsed/refractory (R/R) acute myeloid leukemia (AML) and acute lymphoblastic T leukemia patients (T-ALL).
- Where
- Barcelona, Valencia
- Age
- 18 years and over
- People
- 39
- Run by
- Gyala Therapeutics S.L.
See details and how to join2024-519966-31-00 - Phase 1/2Taking peopleSingle-center phase I/IIa study with CART cells produced using the anti-CD19 transposon technique (TranspoCART19) for patients with CD19+ acute lymphoblastic leukemia resistant or refractory to treatment
- Where
- Pamplona
- People
- 24
- Run by
- Clinica Universidad De Navarra
See details and how to join2025-522673-11-00 - Phase 3Taking peopleStudy on chemotherapy and experimental drugs in patients with Philadelphia Chromosome positive and ABL-class Philadelphia Chromosome-Like B-cell Acute Lymphoblastic Leukemia
- Where
- Barakaldo, Barcelona, Las Palmas de Gran Canaria, Madrid, Malaga, Murcia, Santander, Sevilla, Valencia, Zaragoza
- Age
- Up to 64 years
- People
- 87 worldwide
- Run by
- Universita Degli Studi Di Milano Bicocca
See details and how to join2025-520982-39-00